Daily News Archive
Daily News Subscription
US Horsemen & Regulators "Wide Gap" On Salix
Also in the US, the “conversation about race-day medication continued, when the Drug Testing Standards & Practices Committee of the Association Of Racing Commissioners International met in Saratoga Springs to hear from veterinarians, researchers & horsemen about the use of race-day furosemide, also known as Lasix or Salix” reported thoroughbredtimes.com. Covering “much of the same ground as a similar summit held last month at Belmont Park, the conference indicated that the gap between the positions held by some regulators & the horsemen remains wide”. Representing the horsemen Alan Foreman (president of the Thoroughbred Horsemen’s Association) & Rick Violette (president of New York Thoroughbred Horsemen’s Association) & appearing on behalf of the National HBPA David Basler (chairman of the Ohio Horsemen’s Benevolent & Protective Association) “maintained that Salix is a necessary therapy for horse health”. But leading veterinarian Tom David (chairman of the RCI’s regulatory veterinarians committee) stated that “all race-day medications should be eliminated in all jurisdictions within 5 years”. In March, the RCI “came out in favour of a similar position; a month later, the RCI board voted to re-examine its position on Lasix, leading to this week’s meeting”.